Home

Cale deschizator Proces online dapsa calculator Încredere friptură Centrul orasului

Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative  Capacity and Construct Validity of Six Composite Indices in a Real World
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the  Treat-to-target Concept to Canadian Daily Practice | The Journal of  Rheumatology
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology

Home
Home

Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA)  with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients  with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study -  ACR Meeting Abstracts
Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts

Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic  Arthritis: An Italian Real-Life Retrospective Study
Frontiers | Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study

Disease-specific composite measures for psoriatic arthritis are highly  responsive to a Janus kinase inhibitor treatment that targets multiple  domains of disease | Arthritis Research & Therapy | Full Text
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text

Spearman correlations with the mCPDAI sum at baseline, on week 12 and... |  Download Table
Spearman correlations with the mCPDAI sum at baseline, on week 12 and... | Download Table

JCM | Free Full-Text | DNA Fragmentation in Viable and Non-Viable  Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar  Accuracy | HTML
JCM | Free Full-Text | DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy | HTML

What Should Be the Primary Target of “Treat to Target” in Psoriatic  Arthritis?
What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis?

Disease-specific composite measures for psoriatic arthritis are highly  responsive to a Janus kinase inhibitor treatment that targets multiple  domains of disease | Arthritis Research & Therapy | Full Text
Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease | Arthritis Research & Therapy | Full Text

UvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository)

PsA Remission, Response Cutoffs Identified for DAPSA Tool
PsA Remission, Response Cutoffs Identified for DAPSA Tool

Frontiers | Harnessing Big Data, Smart and Digital Technologies and  Artificial Intelligence for Preventing, Early Intercepting, Managing, and  Treating Psoriatic Arthritis: Insights From a Systematic Review of the  Literature
Frontiers | Harnessing Big Data, Smart and Digital Technologies and Artificial Intelligence for Preventing, Early Intercepting, Managing, and Treating Psoriatic Arthritis: Insights From a Systematic Review of the Literature

Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA  Criteria - Rheumatology Advisor
Psoriatic Arthritis Remission Compared With Very Low Disease Activity, DAPSA Criteria - Rheumatology Advisor

POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN  PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL,  MULTICENTER STUDY | Annals
POS1069 VALIDATION OF THE DISEASE ACTIVITY INDEX FOR PSORIATIC ARTHRITIS ( DAPSA) WITH A QUICK QUANTITATIVE C-REACTIVE PROTEIN ASSAY (Q-DAPSA) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA): A PROSPECTIVE, NATIONAL, MULTICENTER STUDY | Annals

Digital Tools for Assessing Disease Severity in Dermatology. - Abstract -  Europe PMC
Digital Tools for Assessing Disease Severity in Dermatology. - Abstract - Europe PMC

Original article
Original article

PDF) Comparison of disease activity measures in early psoriatic arthritis  in usual care
PDF) Comparison of disease activity measures in early psoriatic arthritis in usual care

Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis  Using Data From an Interventional Study With Golimumab - Helliwell - 2014 -  Arthritis Care & Research - Wiley Online Library
Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab - Helliwell - 2014 - Arthritis Care & Research - Wiley Online Library

Response to: 'To DAPSA or not to DAPSA? That is not the question' by  Schoels et al
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al

Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative  Capacity and Construct Validity of Six Composite Indices in a Real World
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

PDF) Disease Activity in Psoriatic Arthritis: Comparison of the  Discriminative Capacity and Construct Validity of Six Composite Indices in  a Real World | Fausto Salaffi - Academia.edu
PDF) Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World | Fausto Salaffi - Academia.edu

Disease activity in psoriatic arthritis (PsA): defining remission and  treatment success using the DAPSA score | Annals of the Rheumatic Diseases
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases

Comparing methotrexate monotherapy with methotrexate plus leflunomide  combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind,  placebo-controlled, randomised, trial - The Lancet Rheumatology
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology